Literature DB >> 25976195

Pitfalls in the diagnostic evaluation of subacute combined degeneration.

A Ulrich1, D Müller2, M Linnebank1, A A Tarnutzer1.   

Abstract

We report a case of a 43-year-old man presenting with a 2-week history of painless ascending sensory disturbances, suspected to be suffering from acute inflammatory polyneuropathy. On clinical examination, deep tendon reflexes were preserved and muscle strength was 5/5 everywhere. Gait was ataxic with positive Romberg test. Lumbar puncture was normal and electroneurography demonstrated demyelination. With spinal cord involvement centred on the posterior tracts on MRI, differential diagnosis focused on cobalamin deficiency. Initial laboratory work up showed nearly normal holotranscobalamin (43 pmol/L, normal>50) suggesting no vitamin B12 deficiency. Surprisingly, further testing including methylmalonic acid (3732 nmol/L, normal<271) and homocysteine (48.5 µmol/L, normal<10) showed an impairment of vitamin B12-dependent metabolism leading to the diagnosis of subacute combined degeneration. Only after repeated history taking did the patient remember having taken tablets containing cobalamin for 3 days before hospitalisation. In case of B12 deficiency, holotranscobalamin can rapidly normalise during supplementation, whereas methylmalonic acid and homocysteine might help to detect B12 deficiency in patients who recently started supplementation. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25976195      PMCID: PMC4434358          DOI: 10.1136/bcr-2014-208622

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

Review 2.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

3.  Vitamin B12 deficiency: a clinical and electrophysiological profile.

Authors:  V Puri; N Chaudhry; S Goel; P Gulati; R Nehru; D Chowdhury
Journal:  Electromyogr Clin Neurophysiol       Date:  2005 Jul-Aug

4.  Clinical, nerve conduction and nerve biopsy study in vitamin B12 deficiency neurological syndrome with a short-term follow-up.

Authors:  Jayantee Kalita; Satish Chandra; Sanjeev K Bhoi; Ritu Agarwal; Usha Kant Misra; Surala K Shankar; Anita Mahadevan
Journal:  Nutr Neurosci       Date:  2013-11-20       Impact factor: 4.994

5.  Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.

Authors:  M Den Heijer; S Lewington; R Clarke
Journal:  J Thromb Haemost       Date:  2005-02       Impact factor: 5.824

6.  Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.

Authors:  Jameson R Lam; Jennifer L Schneider; Wei Zhao; Douglas A Corley
Journal:  JAMA       Date:  2013-12-11       Impact factor: 56.272

7.  Challenges in the identification of cobalamin-deficiency polyneuropathy.

Authors:  David S Saperstein; Gil I Wolfe; Gary S Gronseth; Sharon P Nations; Laura L Herbelin; Wilson W Bryan; Richard J Barohn
Journal:  Arch Neurol       Date:  2003-09

Review 8.  Copper deficiency myelopathy.

Authors:  Stephan R Jaiser; Gavin P Winston
Journal:  J Neurol       Date:  2010-03-16       Impact factor: 4.849

Review 9.  Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II.

Authors:  Ralph Carmel
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

Review 10.  Cobalamin deficiency: clinical picture and radiological findings.

Authors:  Chiara Briani; Chiara Dalla Torre; Valentina Citton; Renzo Manara; Sara Pompanin; Gianni Binotto; Fausto Adami
Journal:  Nutrients       Date:  2013-11-15       Impact factor: 5.717

View more
  3 in total

1.  Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson's disease.

Authors:  Jin-Sung Park; Donghwi Park; Pan-Woo Ko; Kyunghun Kang; Ho-Won Lee
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

2.  Serum copper decrease and cerebellar atrophy in patients with nitrous oxide-induced subacute combined degeneration: two cases report.

Authors:  Jie Cao; Lusen Ran; Chenchen Liu; Zhijun Li
Journal:  BMC Neurol       Date:  2021-12-04       Impact factor: 2.474

3.  Is serum vitamin B12 decrease a necessity for the diagnosis of subacute combined degeneration?: A meta-analysis.

Authors:  Jie Cao; Shabei Xu; Chenchen Liu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.